Lung preservation: from perfusion to temperature

PURPOSE OF REVIEW This article will review the evidence behind elements of the lung preservation process that have remained relatively stable over the past decade as well as summarize recent developments in ex-vivo lung perfusion and new research challenging the standard temperature for static cold storage. RECENT FINDINGS Ex-vivo lung perfusion is becoming an increasingly well established means to facilitate greater travel distance and allow for continued reassessment of marginal donor lungs. Preliminary reports of the use of normothermic regional perfusion to allow utilization of lungs after DCD recovery exist, but further research is needed to determine its ability to improve upon the current method of DCD lung recovery. Also, research from the University of Toronto is re-assessing the optimal temperature for static cold storage; pilot studies suggest it is a feasible means to allow for storage of lungs overnight to allow for daytime transplantation, but ongoing research is awaited to determine if outcomes are superior to traditional static cold storage. SUMMARY It is crucial to understand the fundamental principles of organ preservation to ensure optimal lung function posttransplant. Recent advances in the past several years have the potential to challenge standards of the past decade and reshape how lung transplantation is performed.

[1]  G. Verleden,et al.  Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study. , 2022, The Journal of Heart and Lung Transplantation.

[2]  S. Keshavjee,et al.  Evaluation of 10°C as the optimal storage temperature for aspiration-injured donor lungs in a large animal transplant model. , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  R. Sade,et al.  Normothermic Regional Perfusion: Ethical Issues in Thoracic Organ Donation. , 2022, The Annals of thoracic surgery.

[4]  G. Snell,et al.  Donation After Circulatory Death in lung transplantation. , 2022, Thoracic surgery clinics.

[5]  B. Suberviola,et al.  Lung transplantation from controlled donation after circulatory death using simultaneous abdominal normothermic regional perfusion: A single center experience , 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  A. Zuckermann,et al.  ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD). , 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  S. Keshavjee,et al.  Ex vivo lung perfusion , 2021, Journal of thoracic disease.

[8]  A. Exadaktylos,et al.  Brain–lung interactions and mechanical ventilation in patients with isolated brain injury , 2021, Critical Care.

[9]  S. Knight,et al.  A systematic review and meta‐analyses of regional perfusion in donation after circulatory death solid organ transplantation , 2021, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  L. Brochard,et al.  Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function , 2021, Science Translational Medicine.

[11]  N. Markin,et al.  Successful lung transplantation with graft recovered after thoracoabdominal normothermic perfusion from donor after circulatory death , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  J. Klapper,et al.  Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience. , 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  D. Paredes,et al.  Consensus statement on normothermic regional perfusion in donation after circulatory death: Report from the European Society for Organ Transplantation’s Transplant Learning Journey , 2021, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  J. Copeland,et al.  Donor heart and lung procurement: A consensus statement. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  J. Madsen,et al.  Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. , 2019, The Lancet. Respiratory medicine.

[16]  G. Meyfroidt,et al.  Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality , 2019, Intensive Care Medicine.

[17]  G. Snell,et al.  Influence of lung donor agonal and warm ischemic times on early mortality: Analyses from the ISHLT DCD Lung Transplant Registry. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  F. Rea,et al.  Pushing the limits of reconditioning: extended normothermic lung perfusion in an extended criteria donor. , 2018, Journal of Thoracic Disease.

[19]  Marco Schiavon,et al.  Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study. , 2018, The Lancet. Respiratory medicine.

[20]  S. Keshavjee,et al.  Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study. , 2017, The Lancet. Respiratory medicine.

[21]  M. Erasmus,et al.  DCD lung donation: donor criteria, procedural criteria, pulmonary graft function validation, and preservation , 2016, Transplant international : official journal of the European Society for Organ Transplantation.

[22]  J. Neuberger,et al.  New classification of donation after circulatory death donors definitions and terminology , 2016, Transplant international : official journal of the European Society for Organ Transplantation.

[23]  Stefan Fischer,et al.  Retrograde in situ versus antegrade pulmonary preservation in clinical lung transplantation: a single-centre experience. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  Katharina M. Busl,et al.  Neurogenic Pulmonary Edema , 2015, Critical care medicine.

[25]  V. Valero,et al.  Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation. , 2015, JAMA surgery.

[26]  S. Keshavjee,et al.  Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  L. M. Anderson,et al.  Innovative cold storage of donor organs using the Paragonix Sherpa Pak ™ devices , 2015, Heart, lung and vessels.

[28]  B. Whitson,et al.  Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature. , 2014, Journal of thoracic disease.

[29]  S. Keshavjee,et al.  Donor management and lung preservation for lung transplantation. , 2013, The Lancet. Respiratory medicine.

[30]  Marcelo Cypel,et al.  Normothermic ex vivo lung perfusion in clinical lung transplantation. , 2011, The New England journal of medicine.

[31]  G. Westall,et al.  Effect of donor preservation solution and survival in lung transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[32]  Arthur S Slutsky,et al.  Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. , 2010, JAMA.

[33]  W. Baumgartner,et al.  Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  G. Verleden,et al.  Retrograde flush following warm ischemia in the non-heart-beating donor results in superior graft performance at reperfusion. , 2009, The Journal of surgical research.

[35]  M. Zenati,et al.  Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. , 2008, The Annals of thoracic surgery.

[36]  R. Stockley,et al.  Early donor management increases the retrieval rate of lungs for transplantation. , 2008, The Annals of thoracic surgery.

[37]  G. Snell,et al.  Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. , 2006, The Annals of thoracic surgery.

[38]  G. Verleden,et al.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[39]  P. Dartevelle,et al.  Graft ischemic time and outcome of lung transplantation: a multicenter analysis. , 2005, American journal of respiratory and critical care medicine.

[40]  Stefan Fischer,et al.  Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. , 2005, The Journal of thoracic and cardiovascular surgery.

[41]  M. Ochs,et al.  Innovative pulmonary preservation of non-heart-beating donor grafts in experimental lung transplantation. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[42]  J. Hohlfeld,et al.  Surfactant function in lung transplantation after 24 hours of ischemia: advantage of retrograde flush perfusion for preservation. , 2002, The Journal of thoracic and cardiovascular surgery.

[43]  Ming Liu,et al.  Prostaglandin E1 protects lung transplants from ischemia-reperfusion injury: a shift from pro- to anti-inflammatory cytokines. , 2001, Transplantation.

[44]  M. Sarsam Preimplantation retrograde pneumoplegia in clinical lung transplantation. , 1999, The Journal of thoracic and cardiovascular surgery.

[45]  Arthur S Slutsky,et al.  Optimal inflation volume for hypothermic preservation of rat lungs. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[46]  D. Follette,et al.  Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[47]  R. Muraoka,et al.  Relationship between flushing pressure and nitric oxide production in preserved lungs. , 1998, Transplantation.

[48]  M. Oz,et al.  cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation. , 1996, Circulation research.

[49]  M. Haniuda,et al.  Effects of inflation volume during lung preservation on pulmonary capillary permeability. , 1996, The Journal of thoracic and cardiovascular surgery.

[50]  R. Muraoka,et al.  Influence of pulmonary arterial pressure during flushing on lung preservation. , 1996, Transplantation.

[51]  G. Patterson,et al.  Free radical-mediated vascular injury in lungs preserved at moderate hypothermia. , 1995, The Annals of thoracic surgery.

[52]  F. Beyersdorf,et al.  Distribution of lung preservation solutions in parenchyma and airways: influence of atelectasis and route of delivery. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[53]  O. H. Lowry,et al.  Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation. , 1993, The Journal of thoracic and cardiovascular surgery.

[54]  J. Cooper,et al.  In a canine model, lung preservation at 10° C is superior to that at 4° C: A comparison of two preservation temperatures on lung function and on adenosine triphosphate level measured by phosphorus 31-nuclear magnetic resonance , 1992 .

[55]  Arthur S Slutsky,et al.  The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation. , 1992, The Journal of thoracic and cardiovascular surgery.